Health Reference Series: Drug Abuse Sourcebook
Health Reference Series: Drug Abuse Sourcebook
Editor/Author
Williams, Angela
Publication Year: 2019
Publisher: Omnigraphics, Inc.
Single-User Purchase Price:
$95.00

Unlimited-User Purchase Price:
$142.50
ISBN: 978-1-78785-295-2
Category: Health & Medicine - Health
Image Count:
50
Book Status: Available
Table of Contents
Drug Abuse Sourcebook, Sixth Edition, provides updated information about the abuse of illegal drugs and the misuse of prescription and over-the-counter medications.
This book is found in the following Credo Collections:
Table of Contents
- Preface
- Part I: Facts and Statistics about Drug Abuse in the United States
- Chapter 1—Prevalence of Drug Abuse in the United States
- Chapter 2—Drugs: Abuse and Addiction
- Section 2.1—What Is Drug Abuse?
- Section 2.2—What Is Drug Addiction?
- Chapter 3—How Drugs Impact Brain
- Chapter 4—Genetics and Epigenetics of Addiction
- Chapter 5—Drug Abuse and Related Hospitalization Costs
- Section 5.1—Substance Abuse Cost to Society
- Section 5.2—Drug-Related Hospital Emergency Room Visits
- Section 5.3—Increase in Emergency Room Visits Related to Ecstasy
- Section 5.4—Deaths from Drug Overdoses
- Chapter 6—Understanding the Legal Use of Controlled Substances
- Section 6.1—Prescriptions for Controlled Substances
- Section 6.2—Is Marijuana Medicine?
- Chapter 7—Regulations Regarding Controlled Substances
- Section 7.1—The Controlled Substances Act and the Schedule Classifications
- Section 7.2—Combat Methamphetamine Epidemic Act
- Chapter 8—Drugs—Shatter the Myths
- Chapter 9—Substance-Abuse Treatment Statistics
- Part II: Drug Abuse and Specific Populations
- Chapter 10—Adolescent Drug Abuse
- Section 10.1—Trends in Adolescent Drug Abuse
- Section 10.2—Reasons Adolescents Try Drugs and Alcohol
- Section 10.3—Adolescents and Prescription-Drug Misuse
- Section 10.4—Adolescent Marijuana Use
- Section 10.5—Adolescents and Opioids
- Section 10.6—School Dropouts and Substance Abuse
- Chapter 11—Drug Use among College Students
- Chapter 12—Substance-Abuse Issues of Concern to Women
- Section 12.1—Alcohol-Use Disorder,Substance-Use Disorder,and Addiction among Women
- Section 12.2—Substance Use While Pregnant and Breastfeeding
- Section 12.3—Negative Consequences of Prenatal Exposure to Drugs
- Section 12.4—What Women Need to Know about Date Rape Drugs
- Chapter 13—Cigarette Smoking and Tobacco Use among People of Low Socioeconomic Status
- Chapter 14—Substance Abuse in the Workplace
- Chapter 15—Seniors and Drug Abuse
- Chapter 16—Substance Abuse in the LGBT Community
- Chapter 17—Substance Abuse in the Racial and Ethnic Minority Populations
- Chapter 18—Drug Abuse in Other Populations
- Section 18.1—Veterans and Drug Abuse
- Section 18.2—Criminal Justice Populations and Substance Abuse
- Section 18.3—Substance-Use Disorders in People with Disabilities
- Part III: Drugs of Abuse
- Chapter 19—Introduction to Drug Classes
- Chapter 20—Anabolic Steroids and Related Drugs Used as Performance Enhancers
- Section 20.1—Anabolic Steroids
- Section 20.2—Clenbuterol
- Section 20.3—Human Growth Hormone (hGH)
- Chapter 21—Cannabinoids
- Section 21.1—Cannabis and Cannabinoids
- Section 21.2—Synthetic Cannabinoids (K2/Spice)
- Chapter 22—Club Drugs
- Section 22.1—What Are Club Drugs?
- Section 22.2—Gamma-Hydroxybutyrate (GHB)
- Section 22.3—Ketamine
- Section 22.4—Rohypnol
- Chapter 23—Dissociative Drugs
- Section 23.1—Dextromethorphan (DXM)
- Section 23.2—Phencyclidine (PCP)
- Section 23.3—Salvia divinorum
- Chapter 24—Hallucinogenic Drugs
- Section 24.1—Introduction to Hallucinogens
- Section 24.2—4-Iodo-2,5-Dimethoxyphenethylamine
- Section 24.3—Alpha-Methyltryptamine (Spirals)
- Section 24.4—Blue Mystic (2C-T-7)
- Section 24.5—DMT
- Section 24.6—Ecstasy (MDMA)
- Section 24.7—Foxy
- Section 24.8—LSD
- Section 24.9—Mescaline (Peyote)
- Section 24.10—Psilocybin
- Section 24.11—Toonies (Nexus, 2C-B)
- Chapter 25—Inhalants
- Chapter 26—Narcotics (Opioids)
- Section 26.1—Introduction to Narcotics
- Section 26.2—Buprenorphine
- Section 26.3—Fentanyl
- Section 26.4—Heroin
- Section 26.5—Hydrocodone
- Section 26.6—Hydromorphone
- Section 26.7—Methadone
- Section 26.8—Oxycodone
- Chapter 27—Sedatives (Depressants)
- Section 27.1—Introduction to Depressants
- Section 27.2—Barbiturates
- Section 27.3—Benzodiazepines
- Section 27.4—Kava
- Chapter 28—Stimulants
- Section 28.1—Introduction to Stimulants
- Section 28.2—Amphetamine
- Section 28.3—BZP
- Section 28.4—Cocaine
- Section 28.5—Khat
- Section 28.6—Kratom
- Section 28.7—Methamphetamine
- Section 28.8—Methylphenidate
- Chapter 29—Synthetic Drugs
- Section 29.1—What Are Synthetic Drugs?
- Section 29.2—Bath Salts
- Chapter 30—Tobacco, Nicotine, and E-Cigarettes
- Part IV: The Causes and Consequences of Drug Abuse and Addiction
- Chapter 31—Drug Addiction Is a Chronic Disease
- Chapter 32—Common Risk and Protective Factors for Drug Use
- Chapter 33—Prescription and Over-the-Counter Drug Abuse
- Section 33.1—Causes and Prevalence of Prescription-Drug Misuse
- Section 33.2—Over-the-Counter Medicines and Their Misuse
- Section 33.3—Misuse of Over-the-Counter Cough and Cold Medicines
- Chapter 34—Legal, Financial, and Social Consequences of Drug Abuse
- Section 34.1—Legal Consequences of Drug Abuse
- Section 34.2—Financial Consequences of Drug Abuse
- Section 34.3—Drugged Driving
- Chapter 35—Health Consequences of Drug Addiction
- Section 35.1—Poor Health Outcomes of Commonly Abused Drugs
- Section 35.2—Substance Abuse and Medical Complications
- Section 35.3—Marijuana's Long-Term Effects on the Brain
- Section 35.4—Opioid Overdose
- Chapter 36—Preventing Disease in Drug-Abusing Populations
- Section 36.1—Drug Abuse and Infectious Diseases
- Section 36.2—The Connection between HIV/AIDS and Drug Abuse
- Section 36.3—Hepatitis Infection and Drug Use
- Section 36.4—Sterile Syringe Programs
- Chapter 37—Mental Illness and Addiction
- Section 37.1—Addiction and Mental-Health Disorders
- Section 37.2—Depression and Initiation of Alcohol and Drug Abuse in Teens
- Chapter 38—Substance Abuse and Suicide Prevention
- Part V: Drug-Abuse Treatment and Recovery
- Chapter 39—Recognizing Drug Use
- Section 39.1—Signs of Drug Use
- Section 39.2—Am I Drug Addicted?
- Section 39.3—How to Identify Drug Paraphernalia
- Chapter 40—Drug-Abuse Intervention
- Chapter 41—Drug-Abuse Treatment in a Healthcare Setting
- Section 41.1—Medical Professionals Need to Identify Substance-Use Disorders
- Section 41.2—Addiction Treatment Neglected in the Healthcare Setting
- Chapter 42—Detoxification
- Chapter 43—Treatment for Drug Addiction: An Overview
- Chapter 44—Medication and Counseling Treatment
- Section 44.1—What Is Medication and Counseling Treatment?
- Section 44.2—Medication and Counseling Treatment—Buprenorphine
- Section 44.3—Medication and Counseling Treatment—Methadone
- Section 44.4—Medication and Counseling Treatment—Naltrexone
- Section 44.5—Medication and Counseling Treatment—Naloxone
- Section 44.6—Medication and Counseling Treatment—Opioid Overdose
- Chapter 45—Treatment for Methamphetamine Addiction
- Chapter 46—Supporting Substance-Abuse Recovery
- Section 46.1—What Is Recovery?
- Section 46.2—Recovery Support Services
- Chapter 47—Know Your Rights: Parity for Mental-Health and Substance-Use Disorder Benefits
- Chapter 48—Employee-Assistance Programs for Substance Abuse
- Chapter 49—Drug Courts
- Part VI: Drug-Abuse Testing and Prevention
- Chapter 50—Drug-Abuse Prevention Begins at Home
- Section 50.1—Talking to Your Child about Tobacco, Alcohol,and Drugs
- Section 50.2—What to Do If Your Teen or Young Adult Has a Problem with Drugs
- Section 50.3—How to Minimize Prescription-Drug Misuse and Abuse among Teens
- Section 50.4—Tips for Parents: The Truth about Club Drugs
- Chapter 51—Drug-Abuse Testing and Prevention in Schools
- Section 51.1—Drug Testing in Schools
- Section 51.2—Drug-Use Prevention Education in Schools
- Chapter 52—Drug Testing
- Section 52.1—Drug Testing
- Section 52.2—Home-Use Drug Testing
- Chapter 53—Preventing Drug Abuse in the Workplace
- Section 53.1—Drug-Free Workplace Policies
- Section 53.2—Drug Testing in the Workplace
- Chapter 54—Substance-Misuse-Prevention Media Campaigns
- Part VII: Additional Help and Information
- Chapter 55—Glossary of Terms Related to Drug Abuse
- Chapter 56—Glossary of Street Terms for Drugs of Abuse
- Chapter 57—Directory of State Substance-Abuse Agencies
- Chapter 58—Directory of Organizations Providing Information about Drug Abuse